Author:
Jain Nishank,Corken Adam L.,Kumar Amudha,Davis Clayton L.,Ware Jerry,Arthur John M.
Abstract
Platelet-dependent mechanisms for excessive clotting and bleeding in CKD remain undefined. Moreover, platelets’ contribution to inflammation, and specifically to CKD, are equally elusive. To date, descriptions of changes in the functional properties of circulating platelets during CKD have provided confusing interpretations. Experimental approaches that can advance our understanding of platelet dysfunction in CKD are needed, and studies that provide mechanistic insights into the dynamic relationships between thrombosis, bleeding, and inflammation associated with CKD will be essential to improve clinical management and outcomes for this vulnerable population. This article summarizes existing literature characterizing platelets in CKD and identifies areas that need further investigation.
Funder
American Society of Nephrology (ASN) Foundation for Kidney Research
National Center for Advancing Translational Sciences
National Institutes of Health
Publisher
American Society of Nephrology (ASN)
Subject
Nephrology,General Medicine
Reference86 articles.
1. Platelet Dysfunction in Renal Failure
2. Primary and secondary platelet aggregation in uraemia;Ballard;Scand J Haematol,1972
3. United States Renal Data System: U.S. renal data system chapter 7 for patients with chronic kidney disease and chapter 10 for patients with end stage renal disease. In: United States Renal Data System 2017 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014. Available at https://www.usrds.org/annual-data-report/previous-adrs/. Accessed December 11, 2017
4. Antiplatelet Medications in Hemodialysis Patients: A Systematic Review of Bleeding Rates
5. Oral P2Y12Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current Knowledge and Future Directions
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献